Patents by Inventor Kathy L. Miller

Kathy L. Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multivalent antibodies and uses therefor
    Patent number: 9493579
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: November 15, 2016
    Assignee: Genentech, Inc.
    Inventors: Kathy L. Miller, Leonard G. Presta
  • MULTIVALENT ANTIBODIES AND USES THEREFOR
    Publication number: 20140322221
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Application
    Filed: March 28, 2014
    Publication date: October 30, 2014
    Applicant: Genentech, Inc.
    Inventors: Kathy L. MILLER, Leonard G. PRESTA
  • Multivalent antibodies and uses therefor
    Patent number: 8722859
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: May 13, 2014
    Assignee: Genentech, Inc.
    Inventors: Kathy L. Miller, Leonard G. Presta
  • COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS
    Publication number: 20130287775
    Abstract: Methods and compositions are provided for the treatment of immune disorders, such as autoimmune diseases, or cancers, involving combination therapy with agents that inhibit the development or maintenance of Th17 cells. Treatment regimens are provided in which an antagonist of a pro-inflammatory cytokine is administered for a time sufficient to alleviate signs and symptoms of an acute phase flare-up of the autoimmune disease, or cancer, and treatment with an antagonist of IL-23 is continued for a longer time to prevent recurrence of the acute event. Antagonists of PGE2 and CD161 are also disclosed for use in treatment of autoimmune, inflammatory and proliferative disorders.
    Type: Application
    Filed: June 24, 2013
    Publication date: October 31, 2013
    Inventors: Edward P. Bowman, Daniel J. Cua, Robert A. Kastelein, Kathy L. Miller, Melanie A. Kleinschek, Kristian S. Bak-Jensen, Katia Boniface, Brent S. McKenzie, Rene de Waal Malefyt
  • MULTIVALENT ANTIBODIES AND USES THEREFOR
    Publication number: 20120238728
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Application
    Filed: May 11, 2012
    Publication date: September 20, 2012
    Applicant: GENENTECH, INC.
    Inventors: Kathy L. Miller, Leonard G. Presta
  • APRIL ANTAGONISTS AND METHODS OF USE
    Publication number: 20120201823
    Abstract: The present invention provides antagonists of APRIL. In particular, the APRIL antagonists block unique receptor binding sited on APRIL, BCMA. TACI, and/or HSPG. Also provided are methods of use.
    Type: Application
    Filed: October 14, 2010
    Publication date: August 9, 2012
    Applicant: Schering Corporation
    Inventors: Mary J. Janatpour, Kathy L. Miller
  • Multivalent Antibodies and Uses Therefor
    Publication number: 20110110852
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Application
    Filed: November 3, 2010
    Publication date: May 12, 2011
    Applicant: Genentech, Inc.
    Inventors: Kathy L. Miller, Leonard G. Presta
  • MULTIVALENT ANTIBODIES AND USES THEREFOR
    Publication number: 20080299120
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Application
    Filed: September 25, 2006
    Publication date: December 4, 2008
    Inventors: Kathy L. Miller, Leonard G. Presta
  • Multivalent antibodies and uses therefor
    Publication number: 20020004587
    Abstract: The present application describes engineered antibodies, with three or more functional antigen binding sites, and uses, such as therapeutic applications, for such engineered antibodies.
    Type: Application
    Filed: March 20, 2001
    Publication date: January 10, 2002
    Applicant: GENENTECH, INC.
    Inventors: Kathy L. Miller, Leonard G. Presta